Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003)
Clinical trial NCT03062800 · UNKNOWN
Trial details
- NCT number
- NCT03062800
- Sponsor
- Qilu Hospital of Shandong University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2020-12-01
- Enrollment
- 232
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.